Compound Detail
CHEMBL505
CHLORPHENIRAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL505 |
| Name | CHLORPHENIRAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SOYKEARSMXGVTM-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
15
Targets
28
Activities
3
Assay Types
18
PK Parameters
20
Publications
4
Known Names
5
Indications
Molecular Properties
274.8
MW (Da)
3.82
ALogP
2
HBA
0
HBD
16.1
PSA (Ų)
0.82
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1950 |
| Availability | OTC |
| Chirality | Racemic |
Indications
Hypersensitivity Influenza, Human Hepatitis B, Chronic Rhinitis, Allergic, Seasonal Sunburn
ATC Classification
R06AB04
chlorphenamine
Level 1: RESPIRATORY SYSTEM
Level 2: ANTIHISTAMINES FOR SYSTEMIC USE
R06AB54
chlorphenamine, combinations
Level 1: RESPIRATORY SYSTEM
Level 2: ANTIHISTAMINES FOR SYSTEMIC USE
Activity Summary
IC50 20 meas. best 8.06
Ki 6 meas. best 9.04
Kd 2 meas. best 8.43
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H1 receptor CHEMBL231 | Ki | 9.04 | 8.5133 | 0.9 | 3 |
| Histamine H1 receptor CHEMBL4701 | Ki | 8.7 | 8.4067 | 2.0 | 3 |
| No relevant target CHEMBL2362975 | Kd | 8.43 | 8.43 | 3.7 | 1 |
| ADMET CHEMBL612558 | Kd | 8.4 | 8.4 | 4.0 | 1 |
| Histamine H1 receptor CHEMBL3943 | IC50 | 8.06 | 8.06 | 8.8 | 1 |
| RBL-2H3 CHEMBL614632 | IC50 | 7.5 | 7.23 | 31.8 | 3 |
| Histamine H1 receptor CHEMBL231 | IC50 | 7.18 | 7.18 | 66.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.96 | 4.936 | 1100.0 | 5 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.41 | 4.81 | 3900.0 | 2 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Solute carrier family 22 member 1 CHEMBL2073670 | IC50 | 4.85 | 4.85 | 14000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1770032 | IC50 | 4.58 | 4.58 | 26000.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 4.48 | 4.48 | 33400.0 | 1 |
| MBT domain-containing protein 1 CHEMBL1287625 | IC50 | 4.47 | 4.47 | 34000.0 | 1 |
| Lethal(3)malignant brain tumor-like protein 1 CHEMBL1287622 | IC50 | 4.39 | 4.39 | 41000.0 | 1 |
| Lethal(3)malignant brain tumor-like protein 3 CHEMBL1287623 | IC50 | 4.38 | 4.38 | 42000.0 | 1 |
| Chloroquine resistance transporter CHEMBL1795182 | IC50 | 4.27 | 4.27 | 54000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 23.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| F | 79.0 | % | Homo sapiens |
| F | 35.0 | % | Homo sapiens |
| Fu | 0.3 | - | - |
| Fu | 0.037 | - | - |
| Fu | 0.3 | - | Homo sapiens |
| Fu | 0.7 | - | Homo sapiens |
| Fu | 0.7 | - | Homo sapiens |
| Fu | 0.056 | - | Homo sapiens |
| MRT | 22.0 | hr | Homo sapiens |
| T1/2 | 22.0 | hr | Homo sapiens |
| T1/2 | 22.0 | hr | Homo sapiens |
| Vd | 5.9 | L.kg-1 | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine